Kenan Sabuncu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Kenan Sabuncu has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
- Mehmet Gokhan Culha
Department of Urology Prof. Dr. Cemil Tascıoglu City Hospital, University of Health Sciences Istanbul Turkey
4 shared publications - Alper Otunctemur
Department of Urology, Cemil Tascioglu City Hospital, University of Health Sciences, Istanbul, Turkey
2 shared publications - Recep Burak Degirmentepe
Department of Urology, School of Medicine, Sakarya University, Sakarya, Turkey
2 shared publications Alper Otunctemur
Department of Urology, University of Health Science, Prof. Dr. Cemil Tascioglu City Hospital, Istanbul, Turkey
1 shared publication- Askeri Çankaya
Department of Surgical Nursing, Faculty of Health Sciences, Fırat University, Elazığ 23270, Türkiye
1 shared publication - Ayla Yavuz Karamanoğlu
Pamukkale Üniversitesi, Sağlık Bilimleri Fakültesi
1 shared publication
Latest Publications
- Open Access
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Acta Cirurgica Brasileira
- Vol. 41
Time-dependent protective effects of syringic acid following testicular torsion–detorsion: an experimental rat model
Purpose: To investigate the protective effects of syringic acid (SA) against testicular ischemia–reperfusion (I/R) injury during different reperfusion periods in an experimental rat model. Methods: Forty-eight male Wistar albino rats were randomly assigned to six groups: control, sham, torsion/detorsion (T/D) 4 h, T/D + SA 4 h, T/D 24 h, and T/D + SA 24 h. Testicular torsion was induced by 720° rotation of the left testis for 2 h, followed by detorsion and 4 or 24 h reperfusion. SA (10 mg/kg) was administered intraperitoneally 30 min before detorsion. Oxidative stress markers, histopathological alterations, and immunohistochemical expressions of apoptotic protease activating factor-1 (APAF-1) and inducible nitric oxide synthase were evaluated. Results: T/D significantly decreased total antioxidant status and glutathione levels while increasing myeloperoxidase activity and APAF-1/inducible nitric oxide synthase (iNOS) expressions compared with controls (p < 0.001). SA treatment restored antioxidant capacity and attenuated inflammatory and apoptotic responses (p < 0.05). Histopathological analyses demonstrated lower Cosentino scores and higher Johnsen scores in SA-treated groups than in untreated T/D groups (p < 0.05). Malondialdehyde levels showed no significant intergroup differences. Conclusion: SA attenuates testicular I/R injury by reducing oxidative stress, inflammation, and apoptosis while preserving spermatogenic function and histological integrity.
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Acta Cirurgica Brasileira
- Vol. 41
Open AccessTime-dependent protective effects of syringic acid following testicular torsion–detorsion: an experimental rat model
Purpose: To investigate the protective effects of syringic acid (SA) against testicular ischemia–reperfusion (I/R) injury during different reperfusion periods in an experimental rat model. Methods: Forty-eight male Wistar albino rats were randomly assigned to six groups: control, sham, torsion/detorsion (T/D) 4 h, T/D + SA 4 h, T/D 24 h, and T/D + SA 24 h. Testicular torsion was induced by 720° rotation of the left testis for 2 h, followed by detorsion and 4 or 24 h reperfusion. SA (10 mg/kg) was administered intraperitoneally 30 min before detorsion. Oxidative stress markers, histopathological alterations, and immunohistochemical expressions of apoptotic protease activating factor-1 (APAF-1) and inducible nitric oxide synthase were evaluated. Results: T/D significantly decreased total antioxidant status and glutathione levels while increasing myeloperoxidase activity and APAF-1/inducible nitric oxide synthase (iNOS) expressions compared with controls (p < 0.001). SA treatment restored antioxidant capacity and attenuated inflammatory and apoptotic responses (p < 0.05). Histopathological analyses demonstrated lower Cosentino scores and higher Johnsen scores in SA-treated groups than in untreated T/D groups (p < 0.05). Malondialdehyde levels showed no significant intergroup differences. Conclusion: SA attenuates testicular I/R injury by reducing oxidative stress, inflammation, and apoptosis while preserving spermatogenic function and histological integrity.
- 4 July 2025
- Published by Academician Publishing
- p. 1-18
Ürogenital Sistem Anatomisi
Bu bölüm, ürogenital sistemin anatomisi hakkında kapsamlı bir bilgi sunmak amacıyla yazılmıştır. Ürogenital sistem, boşaltım ve üreme organlarını içeren karmaşık bir yapıdır ve bu organların anatomik ilişkileri, fonksiyonları ve kanlanmaları detaylı bir şekilde ele alınmıştır. Bu organları üriner ve genital sistem olarak değerlendirmek daha anlaşılır olabilir ancak bu yapılar birbiriyle etkileşim halinde olan ve beraber fonksiyon gören yapılardır. Üriner sistem idrar oluşumu ve atılımını sağlayan organları içerir. Böbrekler, üreterler, mesane ve üretra bu sistemin ana bileşenleridir. Bu fonksiyonel yapıyı sırasıyla değerlendirecek olursak böbrekler esas olarak idrar üretiminde görevlidir. Ardından bu idrar üreterler aracılılığıyla mesaneye aktarılır ve sonrasında üretra aracılığıyla miksiyon yoluyla vücuttan atılır. Genital sistemin ana bileşenleri ise erkeklerde testis, epididim, prostat ve üretradır. Testislerde sperm üretiminin ardından spermler epididim yoluyla seminal vezikül ve prostat salgısıyla beraber ejekülasyon yoluyla yine üretradan atılır. Kadın uterusuna ilerleyen bu spermler overlerden salgılanan ovumun döllenmesini –fertilizasyonu sağlar. Metin, ürogenital sistemin karmaşık yapısını ve bu yapının nasıl işlediğini anlamak için gerekli tüm bilgileri sunmaktadır. Ürogenital sistemin anatomisi, üroloji alanında çalışan sağlık profesyonelleri için kritik bir konudur ve bu tür detaylı bilgiler, klinik uygulamalar açısından büyük önem taşımaktadır. This section is written to provide comprehensive information about the anatomy of the urogenital system. The urogenital system is a complex structure that includes excretory and reproductive organs, and the anatomical relationships, functions, and blood supply of these organs are discussed in detail. It may be more understandable to evaluate these organs as the urinary and genital systems, but these structures interact with each other and function together. The urinary system includes organs that provide urine formation and excretion. The kidneys, ureters, bladder, and urethra are the main components of this system. If we evaluate this functional structure in order, the kidneys are primarily responsible for urine production. Then, this urine is transferred to the bladder via the ureters and then excreted from the body via micturition via the urethra. The main components of the genital system in men are the testicles, epididymis, prostate, and urethra. After sperm production in the testicles, sperm are expelled from the urethra again via ejaculation with the seminal vesicle and prostate secretion via the epididymis. These sperm, which move into the female uterus, provide fertilization of the ovum released from the ovaries. The text provides all the information necessary to understand the complex structure of the urogenital system and how it functions. The anatomy of the urogenital system is a critical issue for healthcare professionals working in the field of urology, and such detailed information is of great importance for clinical practice.
- 4 July 2025
- Published by Academician Publishing
- p. 1-18
Ürogenital Sistem Anatomisi
Bu bölüm, ürogenital sistemin anatomisi hakkında kapsamlı bir bilgi sunmak amacıyla yazılmıştır. Ürogenital sistem, boşaltım ve üreme organlarını içeren karmaşık bir yapıdır ve bu organların anatomik ilişkileri, fonksiyonları ve kanlanmaları detaylı bir şekilde ele alınmıştır. Bu organları üriner ve genital sistem olarak değerlendirmek daha anlaşılır olabilir ancak bu yapılar birbiriyle etkileşim halinde olan ve beraber fonksiyon gören yapılardır. Üriner sistem idrar oluşumu ve atılımını sağlayan organları içerir. Böbrekler, üreterler, mesane ve üretra bu sistemin ana bileşenleridir. Bu fonksiyonel yapıyı sırasıyla değerlendirecek olursak böbrekler esas olarak idrar üretiminde görevlidir. Ardından bu idrar üreterler aracılılığıyla mesaneye aktarılır ve sonrasında üretra aracılığıyla miksiyon yoluyla vücuttan atılır. Genital sistemin ana bileşenleri ise erkeklerde testis, epididim, prostat ve üretradır. Testislerde sperm üretiminin ardından spermler epididim yoluyla seminal vezikül ve prostat salgısıyla beraber ejekülasyon yoluyla yine üretradan atılır. Kadın uterusuna ilerleyen bu spermler overlerden salgılanan ovumun döllenmesini –fertilizasyonu sağlar. Metin, ürogenital sistemin karmaşık yapısını ve bu yapının nasıl işlediğini anlamak için gerekli tüm bilgileri sunmaktadır. Ürogenital sistemin anatomisi, üroloji alanında çalışan sağlık profesyonelleri için kritik bir konudur ve bu tür detaylı bilgiler, klinik uygulamalar açısından büyük önem taşımaktadır. This section is written to provide comprehensive information about the anatomy of the urogenital system. The urogenital system is a complex structure that includes excretory and reproductive organs, and the anatomical relationships, functions, and blood supply of these organs are discussed in detail. It may be more understandable to evaluate these organs as the urinary and genital systems, but these structures interact with each other and function together. The urinary system includes organs that provide urine formation and excretion. The kidneys, ureters, bladder, and urethra are the main components of this system. If we evaluate this functional structure in order, the kidneys are primarily responsible for urine production. Then, this urine is transferred to the bladder via the ureters and then excreted from the body via micturition via the urethra. The main components of the genital system in men are the testicles, epididymis, prostate, and urethra. After sperm production in the testicles, sperm are expelled from the urethra again via ejaculation with the seminal vesicle and prostate secretion via the epididymis. These sperm, which move into the female uterus, provide fertilization of the ovum released from the ovaries. The text provides all the information necessary to understand the complex structure of the urogenital system and how it functions. The anatomy of the urogenital system is a critical issue for healthcare professionals working in the field of urology, and such detailed information is of great importance for clinical practice.
- 4 July 2025
- Published by Academician Publishing
Üroloji Hemşireliği
Ürogenital Sistem Anatomisi Kenan SABUNCU Mehmet Gökhan ÇULHA Üriner Sistem Fizyolojisi Gökhan ÇEVİK Ürolojik Muayene ve Tanı Testlerinde Hemşirenin Rol ve Sorumlulukları Funda BÜYÜKYILMAZ Üst Üriner Sistem Perkütan Girişimleri Seher ÜNVER Ürolojik Laparoskopik Cerrahi Nermin OCAKTAN Ürolojik Robotik Cerrahi Hatice Merve ALPTEKİN Ayfer ÖZBAŞ Ürolojide Lazer Kullanımı Esra EREN Transuretral Rezeksiyon ve Diğer Transuretral Yöntemler Pınar ONGÜN Endoüroloji ve Girişimsel Üroradyolojide Hemşirenin Rolü Banu KATRAN Üriner Sistem Enfeksiyonları ve Hemşirelik Bakımı Rabia GÖRÜCÜ Ezgi SEYHAN AK Üriner Sistem Taş Hastalığı ve Hemşirelik Bakımı Ümmü YILDIZ FINDIK Duygu SOYDAŞ Böbrek Kanseri ve Hemşirelik Bakımı Öykü KARA İkbal ÇAVDAR Üreter Kanseri ve Hemşirelik Bakımı Zeynep TEMİZ Mesane Kanseri ve Hemşirelik Bakımı Askeri ÇANKAYA Meryem YAVUZ van GIERSBERGEN Prostat Kanseri ve Hemşirelik Bakımı Tuğba SINMAZ Ayfer ÖZBAŞ Üretra Kanseri ve Hemşirelik Bakımı Açelya TÜRKMEN Yasemin ÖZHANLI Testis Tümörleri ve Hemşirelik Bakımı Ebru KARAZEYBEK Cafer ÖZDEMİR Penis Kanseri ve Hemşirelik Bakımı Yasemin USLU Üriner Sistem Travmaları ve Hemşirelik Bakımı Ayla YAVUZ KARAMANOĞLU Üriner Kontinans ve Hemşirelik Bakımı Fatma VURAL Nazife Gamze ÖZER ÖZLÜ Üriner Kateterizasyon Uygulamaları Yeliz ÇULHA Kadın Cinsel İşlev Bozukluklarında Hemşirelik Bakımı Çiğdem BİLGE Meltem MECDİ KAYDIRAK Erkek Cinsel İşlev Bozukluklarında Hemşirelik Bakımı Elif GEZGİNCİ AKPINAR
- 4 July 2025
- Published by Academician Publishing
Üroloji Hemşireliği
Ürogenital Sistem Anatomisi Kenan SABUNCU Mehmet Gökhan ÇULHA Üriner Sistem Fizyolojisi Gökhan ÇEVİK Ürolojik Muayene ve Tanı Testlerinde Hemşirenin Rol ve Sorumlulukları Funda BÜYÜKYILMAZ Üst Üriner Sistem Perkütan Girişimleri Seher ÜNVER Ürolojik Laparoskopik Cerrahi Nermin OCAKTAN Ürolojik Robotik Cerrahi Hatice Merve ALPTEKİN Ayfer ÖZBAŞ Ürolojide Lazer Kullanımı Esra EREN Transuretral Rezeksiyon ve Diğer Transuretral Yöntemler Pınar ONGÜN Endoüroloji ve Girişimsel Üroradyolojide Hemşirenin Rolü Banu KATRAN Üriner Sistem Enfeksiyonları ve Hemşirelik Bakımı Rabia GÖRÜCÜ Ezgi SEYHAN AK Üriner Sistem Taş Hastalığı ve Hemşirelik Bakımı Ümmü YILDIZ FINDIK Duygu SOYDAŞ Böbrek Kanseri ve Hemşirelik Bakımı Öykü KARA İkbal ÇAVDAR Üreter Kanseri ve Hemşirelik Bakımı Zeynep TEMİZ Mesane Kanseri ve Hemşirelik Bakımı Askeri ÇANKAYA Meryem YAVUZ van GIERSBERGEN Prostat Kanseri ve Hemşirelik Bakımı Tuğba SINMAZ Ayfer ÖZBAŞ Üretra Kanseri ve Hemşirelik Bakımı Açelya TÜRKMEN Yasemin ÖZHANLI Testis Tümörleri ve Hemşirelik Bakımı Ebru KARAZEYBEK Cafer ÖZDEMİR Penis Kanseri ve Hemşirelik Bakımı Yasemin USLU Üriner Sistem Travmaları ve Hemşirelik Bakımı Ayla YAVUZ KARAMANOĞLU Üriner Kontinans ve Hemşirelik Bakımı Fatma VURAL Nazife Gamze ÖZER ÖZLÜ Üriner Kateterizasyon Uygulamaları Yeliz ÇULHA Kadın Cinsel İşlev Bozukluklarında Hemşirelik Bakımı Çiğdem BİLGE Meltem MECDİ KAYDIRAK Erkek Cinsel İşlev Bozukluklarında Hemşirelik Bakımı Elif GEZGİNCİ AKPINAR
- 23 April 2025
- Published by SAGE Publications in Urologia Journal
- Vol. 92 (3) , 544-549
Factors affecting the success of intravesical onabotulinum toxin A injection in the treatment of refractory idiopathic overactive bladder
Background: Onabotulinum toxin A injection is recommended for overactive bladder (OAB) resistant to medical treatments. However, success is not universal, and factors influencing outcomes remain unclear. This study evaluates the factors affecting the success of onabotulinum toxin A injection in refractory idiopathic OAB. Methods: Data from patients with resistant idiopathic OAB treated with 100 IU onabotulinum toxin A (BOTOX ® , Allergan, Dublin, Ireland) between January 2019 and August 2023 were analyzed. Demographic data and symptom duration were recorded. Patients were evaluated pre- and post-procedure using the overactive bladder symptom score (OABSS) and 3-day bladder diaries. A ⩾50% improvement in OABSS was considered treatment success. Botox was injected at 20 sites (5 IU per site) via 22 Fr rigid cystoscope under sedoanalgesia. Results: A total of 210 patients (80.5% female, n = 169) with a mean age of 53.76 ± 14.90 years were included. Symptom duration averaged 39.82 ± 22.28 months. Wet OAB was diagnosed in 83.3% ( n = 175), while 16.7% ( n = 35) had dry OAB. Pre-procedure mean OABSS was 9.18 ± 1.31, daily micturition 8.67 ± 1.52, urge incontinence 2.57 ± 1.28, nocturia 1.87 ± 0.75, and pad use 2.44 ± 1.24/day. Treatment success was achieved in 82.4% ( n = 173). Conclusion: The degree of patient complaints, particularly daily micturition frequency, significantly affects treatment success. Patients with higher daily micturition may require advanced interventions beyond Botox.
- 23 April 2025
- Published by SAGE Publications in Urologia Journal
- Vol. 92 (3) , 544-549
Factors affecting the success of intravesical onabotulinum toxin A injection in the treatment of refractory idiopathic overactive bladder
Background: Onabotulinum toxin A injection is recommended for overactive bladder (OAB) resistant to medical treatments. However, success is not universal, and factors influencing outcomes remain unclear. This study evaluates the factors affecting the success of onabotulinum toxin A injection in refractory idiopathic OAB. Methods: Data from patients with resistant idiopathic OAB treated with 100 IU onabotulinum toxin A (BOTOX ® , Allergan, Dublin, Ireland) between January 2019 and August 2023 were analyzed. Demographic data and symptom duration were recorded. Patients were evaluated pre- and post-procedure using the overactive bladder symptom score (OABSS) and 3-day bladder diaries. A ⩾50% improvement in OABSS was considered treatment success. Botox was injected at 20 sites (5 IU per site) via 22 Fr rigid cystoscope under sedoanalgesia. Results: A total of 210 patients (80.5% female, n = 169) with a mean age of 53.76 ± 14.90 years were included. Symptom duration averaged 39.82 ± 22.28 months. Wet OAB was diagnosed in 83.3% ( n = 175), while 16.7% ( n = 35) had dry OAB. Pre-procedure mean OABSS was 9.18 ± 1.31, daily micturition 8.67 ± 1.52, urge incontinence 2.57 ± 1.28, nocturia 1.87 ± 0.75, and pad use 2.44 ± 1.24/day. Treatment success was achieved in 82.4% ( n = 173). Conclusion: The degree of patient complaints, particularly daily micturition frequency, significantly affects treatment success. Patients with higher daily micturition may require advanced interventions beyond Botox.
- Open Access
- 9 August 2023
- Published by Springer Nature in African Journal of Urology
- Vol. 29 (1) , 1-5
Chronic kidney disease following nephrectomy for renal tumours: retrospective analysis risk factors
Objective: We aimed to determine factors responsible for chronic kidney disease (CKD) following nephrectomy for renal tumours. Methods: A retrospective study was undertaken in patients underwent partial or radical nephrectomy due to kidney tumour between January 2015 and June 2020. Patients with eGFR above 60 ml/min/1.73m2 were included in the study. Demographic information, surgical features, eGFR values and some comorbidities of patients were recorded. The patients were evaluated for the development of CKD according to the CKD-EPI equation postoperatively. Results: One hundred and sixty-six patients who underwent radical (n = 125) or partial (n = 41) nephrectomy were included to study. According to the logistic regression analysis, radical nephrectomy (adjusted OR 0.139 (95% CI 0.038–0.507), p = 0.003), age (adjusted OR 1.037 (95% CI 1.001–1.074), p = 0.045), preoperative proteinuria (adjusted OR 0.251 (95% CI 0.084–0.750) p = 0.013) and preoperative lower eGFR (adjusted OR 0.943 (95% CI 0.917–0.969) p < 0.001) were determined as independent predictor for development of CKD. Conclusions: CKD is an important disease that causes morbidity and mortality. Age, type of surgery and preoperative eGFR and preoperative proteinuria are an independent risk factor for CKD development. Patients should be informed about this problem before surgery.
- 9 August 2023
- Published by Springer Nature in African Journal of Urology
- Vol. 29 (1) , 1-5
Open AccessChronic kidney disease following nephrectomy for renal tumours: retrospective analysis risk factors
Objective: We aimed to determine factors responsible for chronic kidney disease (CKD) following nephrectomy for renal tumours. Methods: A retrospective study was undertaken in patients underwent partial or radical nephrectomy due to kidney tumour between January 2015 and June 2020. Patients with eGFR above 60 ml/min/1.73m2 were included in the study. Demographic information, surgical features, eGFR values and some comorbidities of patients were recorded. The patients were evaluated for the development of CKD according to the CKD-EPI equation postoperatively. Results: One hundred and sixty-six patients who underwent radical (n = 125) or partial (n = 41) nephrectomy were included to study. According to the logistic regression analysis, radical nephrectomy (adjusted OR 0.139 (95% CI 0.038–0.507), p = 0.003), age (adjusted OR 1.037 (95% CI 1.001–1.074), p = 0.045), preoperative proteinuria (adjusted OR 0.251 (95% CI 0.084–0.750) p = 0.013) and preoperative lower eGFR (adjusted OR 0.943 (95% CI 0.917–0.969) p < 0.001) were determined as independent predictor for development of CKD. Conclusions: CKD is an important disease that causes morbidity and mortality. Age, type of surgery and preoperative eGFR and preoperative proteinuria are an independent risk factor for CKD development. Patients should be informed about this problem before surgery.
- Open Access
- 11 July 2021
- Published by Hindawi Limited in Andrologia
- Vol. 53 (8) , e14150
Re: Penile length and circumference dimensions: A large study in young Italian men
Click on the article title to read more.
- 11 July 2021
- Published by Hindawi Limited in Andrologia
- Vol. 53 (8) , e14150
Open AccessRe: Penile length and circumference dimensions: A large study in young Italian men
Click on the article title to read more.